Financial reports
10-K/A
2023 FY
Annual report (amended)
16 Feb 24
10-K
2023 FY
Annual report
13 Feb 24
10-Q
2023 Q3
Quarterly report
31 Oct 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
7 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
Current reports
8-K
Provides 2024 Financial Guidance and Highlights R&D Priorities
13 Feb 24
8-K
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates
31 Oct 23
8-K
Departure of Directors or Certain Officers
12 Sep 23
8-K
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates
1 Aug 23
8-K
Departure of Directors or Certain Officers
15 Jun 23
8-K
Other Events
8 May 23
8-K
Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
2 May 23
8-K
Provides 2023 Financial Guidance and Updates on Key Clinical Programs
7 Feb 23
8-K
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key
1 Nov 22
8-K
Departure of Directors or Certain Officers
4 Oct 22
Registration and prospectus
S-8
Registration of securities for employees
13 Feb 24
S-8
Registration of securities for employees
30 Jun 23
S-8
Registration of securities for employees
30 Jun 23
S-3ASR
Automatic shelf registration
8 Feb 22
S-8
Registration of securities for employees
11 Jun 21
S-8
Registration of securities for employees
15 Jun 20
S-8
Registration of securities for employees
30 Apr 19
S-3ASR
Automatic shelf registration
14 Feb 19
S-8
Registration of securities for employees
24 May 18
424B2
Prospectus for primary offering
11 Sep 17
Proxies
DEFA14A
Additional proxy soliciting materials
7 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
14 May 21
DEFA14A
Additional proxy soliciting materials
16 Apr 21
DEF 14A
Definitive proxy
16 Apr 21
DEFA14A
Additional proxy soliciting materials
14 May 20
PX14A6G
Letter to shareholders
24 Apr 20
Other
UPLOAD
Letter from SEC
13 Apr 20
CORRESP
Correspondence with SEC
7 Apr 20
UPLOAD
Letter from SEC
25 Mar 20
SEC STAFF
SEC staff action: Order
27 Feb 20
SEC STAFF
SEC staff action: Order
6 Feb 20
CT ORDER
Confidential treatment order
7 Nov 19
CT ORDER
Confidential treatment order
7 Nov 19
CT ORDER
Confidential treatment order
7 Nov 19
CT ORDER
Confidential treatment order
7 Nov 19
CT ORDER
Confidential treatment order
7 Nov 19